Wilbanks Smith & Thomas Asset Management LLC Abiomed Inc Transaction History

Wilbanks Smith & Thomas Asset Management LLC

$3.54 Billion
Q1 2024

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$224.73 - $338.64 $674 - $1,015	-3 Reduced 0.15%	2,036 $504,000
Q1 2022 May 05, 2022	BUY	$277.25 - $366.29 $831 - $1,098	3 Added 0.15%	2,039 $583,000
Q3 2019 Nov 06, 2019	SELL	$175.89 - $279.23 $4,397 - $6,980	-25 Reduced 1.21%	2,036 $362,000
Q2 2019 Aug 07, 2019	SELL	$250.96 - $284.94 $1,254 - $1,424	-5 Reduced 0.24%	2,061 $537,000
Q1 2019 May 13, 2019	SELL	$276.39 - $362.25 $2,763 - $3,622	-10 Reduced 0.48%	2,066 $0
Q3 2018 Nov 14, 2018	SELL	$354.53 - $449.75 $709 - $899	-2 Reduced 0.1%	2,076 $934,000
Q2 2018 Aug 08, 2018	SELL	$278.07 - $446.21 $81,752 - $131,185	-294 Reduced 12.39%	2,078 $850,000
Q1 2018 May 15, 2018	SELL	$192.49 - $295.85 $16,361 - $25,147	-85 Reduced 3.46%	2,372 $690,000
Q4 2017 Feb 07, 2018	BUY	$168.78 - $199.74 $27,173 - $32,158	161 Added 7.01%	2,457 $460,000
Q2 2017 Aug 15, 2017	BUY	N/A	2,296	2,296 $329,000

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wilbanks Smith & Thomas Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wilbanks Smith & Thomas Asset Management LLC with notifications on news.

Account